AEST.MED.INT.HLD.SP.ADR/3 Market Cap ($3.30 Million)
Market Cap & Net Worth: AEST.MED.INT.HLD.SP.ADR/3 (3FMA)
AEST.MED.INT.HLD.SP.ADR/3 market cap. AEST.MED.INT.HLD.SP.ADR/3 (F:3FMA) has a market capitalization of $3.30 Million (€2.82 Million) as of November 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #29309 globally and #2538 in its home market, demonstrating a 0.87% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AEST.MED.INT.HLD.SP.ADR/3's stock price €0.06 by its total outstanding shares 48687585 (48.69 Million). Also see how efficiently does AEST.MED.INT.HLD.SP.ADR/3 generate cash for how efficiently the company converts equity into cash flow.
AEST.MED.INT.HLD.SP.ADR/3 Market Cap History (2019–2026)
AEST.MED.INT.HLD.SP.ADR/3 market cap history from 2019 to 2026. Data shows change from $313.06 Million to $512.29K (-52.42% CAGR). Check AEST.MED.INT.HLD.SP.ADR/3 (3FMA) share price today for real-time trading data and today's change.
AEST.MED.INT.HLD.SP.ADR/3 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AEST.MED.INT.HLD.SP.ADR/3's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore AEST.MED.INT.HLD.SP.ADR/3 equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.01x
AEST.MED.INT.HLD.SP.ADR/3's market cap is 0.01 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $161.66 Million | $645.59 Million | -$586.62 Million | 0.25x | N/A |
| 2022 | $71.15 Million | $670.09 Million | -$76.25 Million | 0.11x | N/A |
| 2023 | $29.03 Million | $682.59 Million | -$37.43 Million | 0.04x | N/A |
| 2024 | $15.14 Million | $755.67 Million | -$19.95 Million | 0.02x | N/A |
| 2025 | $5.29 Million | $722.86 Million | -$53.35 Million | 0.01x | N/A |
Competitor Companies of 3FMA by Market Capitalization
Companies near AEST.MED.INT.HLD.SP.ADR/3 in the global market cap rankings as of November 1, 2026. Also see balance sheet size of AEST.MED.INT.HLD.SP.ADR/3 for a full breakdown of the balance sheet.
Key companies related to AEST.MED.INT.HLD.SP.ADR/3 by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #284 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #901 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #987 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1210 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #284 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $473.19 |
| #901 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €47.80 |
| #987 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1210 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $273.25 |
Market Capitalization of AEST.MED.INT.HLD.SP.ADR/3 (2019–2026)
Market capitalization of AEST.MED.INT.HLD.SP.ADR/3 from 2019 to today. Between 2019 and today, AEST.MED.INT.HLD.SP.ADR/3's market cap moved from $313.06 Million to $ 512.29K, with a yearly change of -52.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €512.29K | -90.32% |
| 2025 | €5.29 Million | -65.04% |
| 2024 | €15.14 Million | -47.84% |
| 2023 | €29.03 Million | -59.20% |
| 2022 | €71.15 Million | -55.99% |
| 2021 | €161.66 Million | -18.86% |
| 2020 | €199.22 Million | -36.36% |
| 2019 | €313.06 Million | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of AEST.MED.INT.HLD.SP.ADR/3 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.30 Million USD |
| MoneyControl | $3.30 Million USD |
| MarketWatch | $3.30 Million USD |
| marketcap.company | $3.30 Million USD |
| Reuters | $3.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AEST.MED.INT.HLD.SP.ADR/3
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency tr… Read more